Frontiers in Cardiovascular Drug Discovery

Front Cover
Atta-ur-Rahman, M. Iqbal Choudhary
Bentham Science Publishers, Nov 1, 2016 - Medical - 388 pages

Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology. The third volume of the series covers the following topics: - P2Y12 receptor agonists -Heart failure pharmacotherapy -Vasopressin and the cardiovascular system -Cerebral small vessel disease -Complement blocking therapeutic strategies -New antiplatelet and anticoagulating agents for gastrointestinal treatments

 

Selected pages

Contents

P2Y12Receptor Antagonists and the Concept of Tailored Strategy
3
Evolution of Heart Failure Pharmacotherapy
62
Receptor Physiology and Clinical Implications
148
A Clinical Review Focusing on Therapeutic Strategies
219
A Prospective Approach for the Treatment of Cardiovascular Diseases
279
Towards Recognition and Reduction of Gastrointestinal Harm
347
SUBJECT INDEX
380
Copyright

Common terms and phrases

ACE inhibitors acute decompensated heart agents anaphylatoxin angiotensin anticoagulant antiplatelet apixaban aspirin associated atherosclerosis binding bleeding blockers blood pressure brain Cangrelor cardiovascular cells cerebral small vessel chronic heart failure chronic systolic heart Clin clinical trials clopidogrel cognitive Coll Cardiol complement activation complement system convertase CSVD dabigatran decompensated heart failure digoxin diuretics dose drug dysfunction effects efficacy ejection fraction enalapril endothelial function haemorrhage heart failure patients hemodynamic HFpEF hospitalization human hypertension hypotension Immunol increased inflammatory inhibition ischemic ivabradine lacunar left ventricular lesions leukoaraiosis levels mediated myocardial infarction nOACs NYHA outcomes P2Y12 receptor pathway peptide pexelizumab placebo plasma platelet platelet aggregation platelet reactivity PMID prasugrel protein randomized reduced renal risk factors rivaroxaban role septic shock small vessel disease statins stent stroke syndrome systolic heart failure target terlipressin therapeutic therapy thienopyridine ticagrelor ticlopidine treatment vascular dementia vasodilation vasodilatory shock vasopressin receptor versus warfarin white matter

Bibliographic information

TitleFrontiers in Cardiovascular Drug Discovery
Volume 3 of Frontiers in Cardiovascular Drug Discovery
EditorsAtta-ur-Rahman, M. Iqbal Choudhary
PublisherBentham Science Publishers, 2016
ISBN1681081636, 9781681081632
Length388 pages
Subjects › 

Medical / Pharmacology
  
Export CitationBiBTeX EndNote RefMan